| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SYNTA PHARMACEUTICALS CORP | 29,891,849 | 122,258,000 | 94.25% | ||
| 2 | CELATOR PHARMACEUTICALS INC | 2,246,469 | 6,650,000 | 5.13% | ||
| 3 | COVIDIEN PLC | 6,572 | 593,000 | 0.46% | ||
| 4 | Agile Therapeutics, Inc. | 24,911 | 217,000 | 0.17% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-14-004541, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
